Page last updated: 2024-10-26

domperidone and Sleep Initiation and Maintenance Disorders

domperidone has been researched along with Sleep Initiation and Maintenance Disorders in 2 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnulf, I1
Konofal, E1
Gauthier, C1
Chedru, F1
Rampello, L1
Raffaele, R1
Nicoletti, G1
Le Pira, F1
Vecchio, I1
Malaguarnera, M1
Drago, F1

Trials

1 trial available for domperidone and Sleep Initiation and Maintenance Disorders

ArticleYear
Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:1

    Topics: Adult; Anorexia; Antiemetics; Cimetidine; Domperidone; Female; Histamine H2 Antagonists; Humans; Mal

1997

Other Studies

1 other study available for domperidone and Sleep Initiation and Maintenance Disorders

ArticleYear
Severe restless legs syndrome presenting as intractable insomnia.
    Neurology, 2004, Apr-27, Volume: 62, Issue:8

    Topics: Chronic Disease; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, D

2004